Literature DB >> 25281394

NKG2A expression and impaired function of NK cells in patients with new onset of Graves' disease.

Yupan Zhang1, Guoyue Lv2, Xiaoqian Lou3, Di Peng4, Xiaozhang Qu5, Xige Yang6, Desalegn Admassu Ayana7, Hui Guo8, Yanfang Jiang9.   

Abstract

BACKGROUND: Graves' disease (GD) is an organ-specific autoimmune disease. A significant decrease of the distribution of NK cells in the peripheral blood in children and adolescents with untreated GD has been observed. However, the role of NK and its subsets in adults with GD remains unclear.
METHODS: A total of 28 adult patients with new onset of GD and 23 healthy controls (HC) were recruited. The number of activated inhibitory NK cells in peripheral blood of individual subjects was determined by flow cytometry.
RESULTS: The number of CD3(-)CD56(+) and CD3(-)CD16(+)NK cells in peripheral blood was significantly decreased in the GD patients than the HC. Compared to the HCs, decreased number of NKG2D(+), NKG2C(+), NKp30(+) and NKG2A(+) NK cells and increased number of KIR3DL1(+) NK cells were detected in the GD patients. Moreover, the number of inducible CD107a(+) and IFN-γ-secreting NK cells in GD patients significantly decreased than those in HC. Interestingly, the number of NKG2A(+)NK cells was negatively correlated with the level of serum TRAb in GD patients.
CONCLUSION: Our data indicate that decreased number and impaired function of NK cells may contribute to the pathogenesis of GD.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  GD; KIR3DL1; NK; NKG2A; NKG2D; NKP30

Mesh:

Substances:

Year:  2014        PMID: 25281394     DOI: 10.1016/j.intimp.2014.09.020

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

Review 1.  Trial Watch: Immunotherapy plus radiation therapy for oncological indications.

Authors:  Erika Vacchelli; Norma Bloy; Fernando Aranda; Aitziber Buqué; Isabelle Cremer; Sandra Demaria; Alexander Eggermont; Silvia Chiara Formenti; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2016-07-25       Impact factor: 8.110

Review 2.  Implications of NKG2A in immunity and immune-mediated diseases.

Authors:  Xiaotong Wang; Huabao Xiong; Zhaochen Ning
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

3.  [Research on the negative immune regulation of NK cells in patients with primary immune thrombocytopenia].

Authors:  Y J Zhang; W Qu; H Liu; Y H Wang; C Y Liu; L J Li; H Q Wang; R Fu; L M Xing; Z H Shao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-05-14

4.  RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses.

Authors:  Todd Bradley; Dimitra Peppa; Isabela Pedroza-Pacheco; Dapeng Li; Derek W Cain; Ricardo Henao; Vaishnavi Venkat; Bhavna Hora; Yue Chen; Nathan A Vandergrift; R Glenn Overman; R Whitney Edwards; Chris W Woods; Georgia D Tomaras; Guido Ferrari; Geoffrey S Ginsburg; Mark Connors; Myron S Cohen; M Anthony Moody; Persephone Borrow; Barton F Haynes
Journal:  Cell       Date:  2018-09-27       Impact factor: 41.582

Review 5.  Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher.

Authors:  Daniela Gallo; Eliana Piantanida; Matteo Gallazzi; Luigi Bartalena; Maria Laura Tanda; Antonino Bruno; Lorenzo Mortara
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-17       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.